Merck · 4 days ago
Associate Principal Scientist, Antibody Discovery Innovation
Merck is committed to being the world’s premier biopharmaceutical company, focusing on breakthrough science to create life-changing medicines. The Associate Principal Scientist will lead initiatives in antibody discovery, optimizing processes and collaborating with cross-functional teams to enhance drug discovery efforts.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Propose and lead technology development initiatives to further optimize existing in vivo de novo platforms to increase hits and decrease timelines
Serve as the antibody discovery representative on project teams to help define Target Candidate Profiles (TCP) and lead de novo hit finding strategies and campaigns
Potential for future development opportunities to lead Biologics discovery projects in collaboration with therapeutic area scientists
Stay abreast of external advancements in the relevant scientific fields
Promote the external reputation of our company’s Discovery Biologics department
Qualification
Required
Ph.D. with 4+ years or Master's with 8+ years relevant industry experience
Experience in antibody drug discovery supporting therapeutic programs
Excellent communication and collaboration skills
Ability to manage multiple projects simultaneously
Depth of knowledge in adaptive immunity and B-cell biology and direct application towards optimizing antibody drug discovery and development campaigns
Track record of driving scientific and platform innovations
Experience leading therapeutic antibody discovery campaigns
Strong hands-on laboratory skills, including but not limited to cell culture, molecular biology, assay development, and flow cytometry
Established external reputation through publications, presentations, and/or scientific community engagement
Antibody Discovery
Drug Discovery Process
High-Throughput Screening
Innovation
Machine Learning (ML)
Microfluidics
Molecular Biology Techniques
Project Coordination
Team Strategy
Therapeutic Antibodies
Therapeutic Proteins
Preferred
Ideal candidate will have experience in protein therapeutics beyond traditional mAbs including alternative non-Ig scaffolds, bi- or multi-specifics, fusion proteins, and ADCs
Benefits
Medical
Dental
Vision healthcare and other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
2026-01-08
2026-01-08
2026-01-08
Company data provided by crunchbase